Mitchell & Pahl Private Wealth LLC Acquires 1,013 Shares of Nutrien Ltd. (NYSE:NTR)

Mitchell & Pahl Private Wealth LLC lifted its holdings in Nutrien Ltd. (NYSE:NTRFree Report) by 8.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,536 shares of the company’s stock after acquiring an additional 1,013 shares during the period. Mitchell & Pahl Private Wealth LLC’s holdings in Nutrien were worth $561,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in NTR. Mercer Global Advisors Inc. ADV lifted its stake in Nutrien by 8.3% in the second quarter. Mercer Global Advisors Inc. ADV now owns 4,660 shares of the company’s stock worth $237,000 after purchasing an additional 356 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in Nutrien by 37.3% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 13,427 shares of the company’s stock worth $679,000 after purchasing an additional 3,645 shares during the last quarter. Ensign Peak Advisors Inc lifted its stake in Nutrien by 2.2% in the second quarter. Ensign Peak Advisors Inc now owns 37,839 shares of the company’s stock worth $1,996,000 after purchasing an additional 800 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in Nutrien by 56.3% in the second quarter. EverSource Wealth Advisors LLC now owns 1,680 shares of the company’s stock worth $86,000 after purchasing an additional 605 shares during the last quarter. Finally, Marshall Wace LLP bought a new stake in Nutrien in the second quarter worth about $14,305,000. Institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

Shares of NTR opened at $51.29 on Wednesday. The company has a market cap of $25.19 billion, a price-to-earnings ratio of 34.42, a price-to-earnings-growth ratio of 1.15 and a beta of 0.81. Nutrien Ltd. has a twelve month low of $43.69 and a twelve month high of $60.87. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The company has a 50 day moving average of $47.12 and a two-hundred day moving average of $47.88.

Nutrien (NYSE:NTRGet Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.04). The firm had revenue of $5.35 billion during the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a net margin of 2.79% and a return on equity of 6.99%. Nutrien’s revenue was down 5.0% on a year-over-year basis. During the same quarter last year, the business earned $0.35 earnings per share. As a group, analysts predict that Nutrien Ltd. will post 3.5 earnings per share for the current fiscal year.

Nutrien Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st were paid a $0.939 dividend. This represents a $3.76 annualized dividend and a yield of 7.32%. This is an increase from Nutrien’s previous quarterly dividend of $0.54. The ex-dividend date was Tuesday, December 31st. Nutrien’s dividend payout ratio (DPR) is 144.97%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. UBS Group downgraded shares of Nutrien from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $66.00 to $51.00 in a research note on Thursday, October 10th. Raymond James raised shares of Nutrien from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. Barclays reaffirmed an “equal weight” rating and set a $56.00 target price (up from $55.00) on shares of Nutrien in a research report on Tuesday. Piper Sandler raised shares of Nutrien from an “underweight” rating to an “overweight” rating and raised their target price for the stock from $50.00 to $58.00 in a research report on Monday, January 13th. Finally, Wells Fargo & Company lowered shares of Nutrien from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $62.00 to $50.00 in a research report on Tuesday, September 24th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $58.39.

View Our Latest Stock Report on Nutrien

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.